Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
about
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Is lipid signaling through cannabinoid 2 receptors part of a protective system?Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationThe endocannabinoid system as an emerging target of pharmacotherapyThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetA molecular link between the active component of marijuana and Alzheimer's disease pathologyAlzheimer's disease; taking the edge off with cannabinoids?CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseasePotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's DiseaseEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsExpression Analysis of CB2-GFP BAC Transgenic MiceInteraction between Cannabinoid System and Toll-Like Receptors Controls InflammationBrain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjectsABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARCFunctional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depressionCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsThe CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathwayTargeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly.The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Microglial Activation in the Pathogenesis of Huntington's Disease.A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptorTargeting the endocannabinoid system in Alzheimer's disease.Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modalityEndocannabinoids in synaptic plasticity and neuroprotection.CB2: a cannabinoid receptor with an identity crisisThe endocannabinoid system as a target for the treatment of neurodegenerative disease.Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptorsValidating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity.[¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's diseaseEpigenetic regulation of fatty acid amide hydrolase in Alzheimer diseaseEndocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalCB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides.Evaluation of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.Molecular reorganization of endocannabinoid signalling in Alzheimer's disease
P2860
Q21093231-A86AE0A3-9FB3-43AC-A2D8-F08812B4D07FQ24633122-89DA1145-52EE-4CA2-9DE3-DDD2B2A23B99Q24647850-83D16D18-B6B3-4834-ADA8-7A37EB191E1FQ24648473-69CA4CA8-3C3C-4497-9410-C1DB82CE9E0DQ24650098-6CC09C57-4571-4486-9721-7A7456E8A591Q24657485-F5F2D1CD-90F6-43B7-AE9B-8744C0B4B0E6Q24681412-33B66B2B-E461-4322-BBBE-47EB3A8744FCQ26746050-34B412E7-49A4-49C4-AAFE-AB2EEEA02C1DQ26783325-0BCAEE5B-F1CF-41C6-A991-0B7E3A3DFFDAQ27009220-39EDC459-F2AD-458D-95BE-695F5F0D0579Q27316448-ED5AB9DD-82E2-49B8-AD46-EA0BB35AE06CQ28066215-C415759B-E186-4233-BD43-F7B532333FD5Q28472191-50B710CD-2A9A-4B35-BE20-D94ADF95BC51Q28509608-3AF2847D-E2B1-4281-B4ED-830EAB808F89Q28566269-BFD27538-3723-42D9-9A03-C2742C9823C8Q28568772-C5D73DB2-EBE8-4402-8336-EB53D57FF308Q29306901-AE83EC59-6305-4246-B39F-867F8069A746Q33604098-FA12457E-5736-4EF4-9C60-341F2E93FFA9Q33616120-C892ABA7-8C0C-4A2C-9836-99DD2C804F84Q33630562-A7CC28FC-2A65-4AD1-8F94-E73F02302E28Q33664105-E7529B77-5358-4A5E-BAAA-AE57A0EE41D7Q33809556-47A2307C-83B9-41AC-A76D-43FD58AC72ECQ33885350-4DC5CC5F-00C4-49DF-B2D2-016726BE5C73Q33930000-844E887A-E1D3-4E4D-9090-89DAED9BFC9DQ33997873-1C730B10-D44E-40D5-A024-F4DCCA068A3CQ34018061-10D17D11-91FD-4B5B-B23D-969A9A18EBAFQ34084682-6906561E-94E6-4726-B71B-AAFC51D04417Q34098185-8F336BE1-1F51-4751-801C-D378AB4FEDE3Q34098196-1A228282-70CF-4C2C-B111-8D44E0F89FF1Q34116825-B0BC0672-8A85-40E7-B253-BECE6BFA0AF9Q34241636-48A33D1C-397B-4524-83B1-6375C1A76DC5Q34269852-8B7669F4-45EC-4111-A46C-C93071ADB905Q34312272-DB76BC4A-8CE3-4520-B9AE-3606F12504B9Q34352311-867A9B59-CA3E-4A0E-A4AD-C7C2D479745EQ34403197-84E41DBE-C13A-4523-ABDD-8CFB2B4EA9F0Q34525138-65AC214D-D1E4-4810-A32F-441432B5639FQ34533857-9911653A-D129-499B-A66E-202BF357DA56Q34631608-55FB7C93-1359-49BC-BC3F-856EB26FC951Q34680801-121FC1BD-1D69-4F28-9228-DF43E789987AQ34754667-11E86CB1-E485-46F1-A70E-42C7F3FE6B2B
P2860
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@ast
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@en
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@nl
type
label
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@ast
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@en
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@nl
prefLabel
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@ast
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@en
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@nl
P2093
P921
P3181
P1476
Cannabinoid CB2 receptors and ...... in Alzheimer's disease brains
@en
P2093
Alberto Rábano
Cecilia J Hillard
Cristina Benito
Erica J Carrier
Estefanía Núñez
Rosa M Tolón
P304
11136-11141
P3181
P356
10.1523/JNEUROSCI.23-35-11136.2003
P407
P577
2003-12-01T00:00:00Z